Published in Obesity and Diabetes Week, June 13th, 2005
The company reported a net loss of $2,000,243, or $0.05 per share, for the quarter ended March 31, 2005, compared with a net loss of $1,234,638, or $0.04 per share, for the same period in 2004. Weighted-average common shares outstanding for the quarters ended March 31, 2005, and March 31, 2004, were 39.7 million and 31.6 million, respectively.
Total operating expenses were $2,041,678 and $1,241,166 for the quarters ended March 31, 2005 and 2004, respectively. General and administrative expenses increased to $637,881 in the 2005 period from $594,069 in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.